Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Federal Trade Commission
Chinese Patent Office
Merck
Farmers Insurance
Mallinckrodt
McKinsey
US Department of Justice
Accenture
Queensland Health

Generated: August 22, 2017

DrugPatentWatch Database Preview

CEFTAZIDIME IN DEXTROSE CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Ceftazidime In Dextrose Container, and when can generic versions of Ceftazidime In Dextrose Container launch?

Ceftazidime In Dextrose Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in CEFTAZIDIME IN DEXTROSE CONTAINER is ceftazidime. There are seventeen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ceftazidime profile page.

Summary for Tradename: CEFTAZIDIME IN DEXTROSE CONTAINER

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list256
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CEFTAZIDIME IN DEXTROSE CONTAINER at DailyMed

Pharmacology for Tradename: CEFTAZIDIME IN DEXTROSE CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun
CEFTAZIDIME IN DEXTROSE CONTAINER
ceftazidime
INJECTABLE;INJECTION050823-001Jun 13, 2011RXYesNo► Subscribe► Subscribe► Subscribe
B Braun
CEFTAZIDIME IN DEXTROSE CONTAINER
ceftazidime
INJECTABLE;INJECTION050823-002Jun 13, 2011RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Cantor Fitzgerald
Deloitte
Chubb
Merck
Dow
Teva
Queensland Health
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot